AspenBio (APPY) Closes 1.95M Common Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
AspenBio Pharma (APPY) Prices 1.47M Offering at $2.10
November 15, 2012 8:12 AM ESTAspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, announced today the pricing of its previously announced underwritten public offering. The company is offering 1,476,000 shares of common stock at an offering price of $2.10 per share. The gross proceeds to AspenBio from this offering are... More
AspenBio Pharma (APPY) Announces Common Offering
November 14, 2012 4:51 PM ESTAspenBio Pharma, Inc. (Nasdaq: APPY) announced its intention, subject to market and other conditions, to commence a public offering of its common stock. AspenBio intends to use the net proceeds from this offering for general corporate purposes, including conducting a clinical trial for its... More
